Cargando…
Leuconostoc sp. Meningitis in a Patient Treated with Rituximab for Mantle Cell Lymphoma
We present a 64-year-old man who was treated with R-CHOP (rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisolone) chemoimmunotherapy for mantle cell lymphoma and developed purulent meningitis, probably caused by Leuconostoc sp. The patient had severe hypogammaglobulinemia, which...
Autores principales: | Holik, Hrvoje, Coha, Božena, Šiško, Marijan, Tomić-Paradžik, Maja |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Galenos Publishing
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4563205/ https://www.ncbi.nlm.nih.gov/pubmed/26376594 http://dx.doi.org/10.4274/tjh.2013.0149 |
Ejemplares similares
-
PB2188: PROTON PUMP INHIBITORS ARE SAFE AND EFFECTIVE IN PATIENTS WITH ESSENTIAL THROMBOCYTHEMIA AND POLYCYTHEMIA VERA TREATED WITH LOW-DOSE ASPIRIN
por: Krecak, Ivan, et al.
Publicado: (2023) -
Mantle cell lymphoma with aseptic meningitis mimicking hydrocephalus on brain imaging
por: Samizo, Satoshi, et al.
Publicado: (2022) -
Leuconostoc lactis- A Rare Cause of Bacterial Meningitis in an Immunocompromised Host
por: Omori, Reo, et al.
Publicado: (2020) -
Gastrointestinal Perforation after Rituximab Therapy in Mantle Cell Lymphoma: A Case Report
por: Adashek, Michael, et al.
Publicado: (2018) -
Early Onset Neutropenia due to Rituximab Therapy in Mantle Cell Lymphoma: A Case Report
por: Nelson, Blessie Elizabeth, et al.
Publicado: (2021)